ORION OYJ ADR Reported Earnings

ORION OYJ ADR (ORINY) reported earnings of $0.58 per share on revenue of $606.38 million for the . . Revenue grew 28.31% on a year-over-year basis.

Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company's core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland.